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Carbon Monoxide Neurotransmission Activated
by CK2 Phosphorylation of Heme Oxygenase-2
ties of CO, which are sufficient to activate endogenous
sGC (Ingi and Ronnett, 1995). Endogenously produced
CO also regulates cGMP levels and odorant adaptation
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David Shugar,4 and Solomon H. Snyder1,2,3,* in olfactory receptor neurons of salamanders and inver-
tebrates (Gelperin et al., 2000; Leinders-Zufall et al.,1Department of Neuroscience
2 Department of Pharmacology 1995; Zufall and Leinders-Zufall, 1997). Furthermore, HO
inhibitors block odorant-induced cGMP production inand Molecular Sciences
3 Department of Psychiatry and Behavioral Sciences rat ORNs (Verma et al., 1993).
The strongest evidence for a role of CO in neurotrans-Johns Hopkins University School of Medicine
725 North Wolfe Street mission comes from studies of nonadrenergic, noncho-
linergic (NANC) neurotransmission in the enteric nervousBaltimore, Maryland 21205
4 Institute of Biochemistry and Biophysics system. NANC transmission is substantially reduced by
HO inhibitors (Ny et al., 1996; Rattan and Chakder, 1993;Polish Academy of Sciences
5a Pawinskiego Street Werkstrom et al., 1997) and in mice with genomic dele-
tion of HO2 (Xue et al., 2000; Zakhary et al., 1997). Nitric02-106 Warsaw
Poland oxide (NO) and CO appear to be coneurotransmitters in
the gut, as HO2 and neuronal NO synthase (nNOS) are
both enriched in the myenteric neuronal plexus (Battish
et al., 2000; Ny et al., 1997; Zakhary et al., 1997), andSummary
NANC neurotransmission, reduced in nNOS-deleted
mice (Zakhary et al., 1997), is virtually abolished in miceCarbon monoxide (CO) is a putative gaseous neuro-
transmitter that lacks vesicular storage and must be with deletion of both HO2 and nNOS (Xue et al., 2000).
Cyclic GMP levels are similarly reduced in intestinalsynthesized rapidly following neuronal depolarization.
We show that the biosynthetic enzyme for CO, heme preparations from nNOS and HO2 knockout mice (Zakh-
ary et al., 1997).oxygenase-2 (HO2), is activated during neuronal stim-
ulation by phosphorylation by CK2 (formerly casein Unlike conventional neurotransmitters, gases cannot
be stored in synaptic vesicles. Therefore, release of NOkinase 2). Phorbol ester treatment of hippocampal cul-
tures results in the phosphorylation and activation of or CO upon neuronal depolarization requires rapid acti-
vation of their biosynthetic enzymes. NO is generated byHO2 by CK2, implicating protein kinase C (PKC) in CK2
stimulation. Odorant treatment of olfactory receptor the calcium/calmodulin-dependent activation of nNOS
during neuronal activity (Bredt and Snyder, 1990). Weneurons augments HO2 phosphorylation and activity
as well as cyclic guanosine monophosphate (cGMP) previously reported that treatment of neuronal cultures
with phorbol esters increases HO2 activity in a proteinlevels, with all of these effects selectively blocked by
CK2 inhibitors. Likewise, CO-mediated nonadrener- kinase C (PKC)-dependent manner (Dore et al., 1999).
However, no direct molecular mechanism for depolar-gic, noncholinergic (NANC) relaxation of the internal
anal sphincter requires CK2 activity. Our findings pro- ization-induced activation of HO2 during neuronal activ-
ity has been reported, which has led to skepticism aboutvide a molecular mechanism for the rapid neuronal
activation of CO biosynthesis, as required for a gas- the physiologic role of CO as a neurotransmitter (Cary
and Marletta, 2001).eous neurotransmitter.
In this study, we have examined the molecular mecha-
nisms by which neuronal depolarization leads to in-Introduction
creased HO2 activity and subsequent CO synthesis. We
discovered that HO2 is regulated by a protein kinaseCarbon monoxide (CO) is generated in neurons by the
enzymatic cleavage of heme by heme oxygenase-2 cascade that ultimately leads to the direct phosphoryla-
tion and enzymatic activation of HO2 by the protein(HO2). Abundant evidence suggests that CO can func-
tion as a neurotransmitter (reviewed in Baranano and kinase CK2 (formerly known as casein kinase 2), re-
sulting in CO-dependent neurotransmission. These re-Snyder, 2001). Like nitric oxide (NO), endogenously pro-
duced CO stimulates soluble guanylate cyclase (sGC) sults provide a mechanistic basis for the activation of CO
biosynthesis following neuronal activity, as expected foractivity, increasing cGMP levels in target cells (Ingi et
al., 1996a, 1996b; Ingi and Ronnett, 1995; Leffler et al., a gaseous neurotransmitter/neuromodulator.
1999; Leinders-Zufall et al., 1995; Zakhary et al., 1997;
Zufall and Leinders-Zufall, 1997). HO2 and sGC expres- Results
sion overlap in many regions of the brain, including areas
such as the olfactory bulb, which are devoid of the neu- In Vitro Phosphorylation and Activation
ronal NO synthesizing enzyme nitric oxide synthase of HO2 by CK2
(nNOS) (Bredt et al., 1991; Verma et al., 1993). Olfactory To determine whether phosphorylation regulates the en-
receptor neurons (ORNs) generate micromolar quanti- zymatic activity of HO2, we examined the ability of pro-
tein kinases to influence HO2 activity in vitro. Sequence
analysis indicates that HO2 possesses consensus se-*Correspondence: ssnyder@jhmi.edu
Neuron
130
Figure 1. CK2 Phosphorylates and Stimu-
lates HO2 Activity In Vitro
(A) Human HO2 was expressed in COS-7 cells
and immunoprecipitated, and kinase reac-
tions were performed for the indicated times
with purified CK2. The CK2 inhibitor TBB was
included at a final concentration of 10 M.
(B) Extended time course of the phosphoryla-
tion of HO2 by CK2. Data are presented as
the mean  SEM of four determinations.
(C) HO2 contains three consensus sequences
for CK2 phosphorylation at serines 79 and
179 and threonine 248. Potential phosphory-
lation sites are indicated in bold, and acidic
residues are in italics. Enzymatic activity 
CK2 of wild-type (wt) HO2 and HO2 in which
serines 79 and 179 and threonine 248 were
converted to alanine (S79A, S179A, and
T248A, respectively). Results are expressed
as nmoles [55Fe]hemin cleaved per mg protein
per minute from a representative experiment
of four separate determinations.
(D) HO2 activity as percent of control (un-
phosphorylated) pooled from four separate
determinations. Data are expressed as the
mean  SEM. p values (versus wt) are indi-
cated. Dashed line indicates activity in the
absence of CK2 phosphorylation.
quences for phosphorylation by CK2, cyclic AMP- S79A HO2 results in negligible [32P]ATP incorporation
when analyzed on SDS-PAGE (data not shown), anddependent protein kinase (PKA), cyclic GMP-dependent
protein kinase (PKG), and PKC. Purified CK2 22 holo- phosphopeptide analysis reveals no prominent phos-
phopeptides (Figure 2B). Western blotting indicates aenzyme stoichiometrically phosphorylates HO2 in vitro
(Figures 1A and 1B). In contrast, we detect only minimal similar amount of S79A expression compared to wt (data
not shown). Taken together, the data in Figures 1 andphosphorylation of HO2 by PKA, PKG, and PKC, with
less than 10% of the phosphorylation produced by CK2 2 strongly support S79 as the predominant in vitro CK2
phosphorylation site.(data not shown). CK2 phosphorylation is prevented by
the CK2-specific inhibitor 4,5,6,7-tetrabromobenzotria-
zole (TBB), which inhibits CK2 with a half-maximal effec- Phorbol Esters Stimulate HO2 in Hippocampal
Cultures via PKC-Dependent Activation of CK2tive concentration (Ki) of 0.6 M. TBB is one of the most
selective protein kinase inhibitors known, and when Exposure of hippocampal cultures for 24 hr to phorbol
12-myristate 13-acetate (PMA), a PKC activator, in-tested against a panel of 33 serine/threonine and tyro-
sine protein kinases, only three exhibited moderate inhi- creases HO activity and levels of bilirubin in hippocam-
pal cultures (Dore et al., 1999). In the present experi-bition by TBB, with Ki values one to two orders of magni-
tude higher than that for CK2 (Sarno et al., 2001). ments, we acutely treated primary hippocampal cultures
with PMA for 5 min to evaluate rapid changes in HO2Phosphorylation of HO2 with purified CK2 in vitro leads
to a 100% increase in HO2 catalytic activity (Figures activity associated with PKC activation. Exposure of
hippocampal cultures to 500 nM PMA elicits a 300%1C and 1D). The HO2 assays were performed in the
presence of saturating substrate and were linear over increase in enzymatic activity, which is abolished
by pretreatment with the PKC inhibitor GF 109203Xtime (data not shown), so that increases in catalytic
activity most likely represent changes in Vmax. (GFX) or TBB (Figures 3A and 3B). A structurally related
but much less potent analog of TBB, 5,6-dichloro-1-The minimal consensus motif for phosphorylation by
CK2 is a serine (S) or threonine (T) followed by acidic (-D-ribofuranosyl) benzimidazole (DRB) (Szyszka et al.,
1995), fails to block PMA-induced activation of HO2amino acids, preferably more than one (Pinna, 2002).
Three potential CK2 phosphorylation sites are present when used at the same concentration as TBB (Figures
3A and 3B). In cultures labeled with [32P]orthophosphate,within the HO2 sequence (Figure 1C). To assess the
site(s) of HO2 phosphorylation, we measured CK2-stim- PMA causes a substantial increase in HO2 phosphoryla-
tion, which is blocked by PKC and CK2 inhibitors (Figureulated activity of HO2 in which S79, S179, and T248 had
been mutated to alanine (A). CK2 activation is abolished 3C). Phosphopeptide mapping of HO2 purified from
PMA-treated cultures reveals a single prominent phos-by the S79A mutation but preserved in S179A and T248A
mutations, indicating that S79 is the target of CK2- phopeptide with the same mobility as the phosphopep-
tide produced by in vitro CK2 phosphorylation (Figuredependent activation of HO2 (Figures 1C and 1D).
To further confirm the phosphorylation site of HO2 by 2C), indicating that the same site is phosphorylated in
intact cells. Several minor spots are also evident thatCK2, we conducted phosphopeptide mapping of in vitro
phosphorylated HO2 (Figures 2A and 2B). We observe are not seen when HO2 is phosphorylated in vitro, which
may reflect phosphorylation by other kinases.a single prominent phosphopeptide when wild-type (wt)
HO2 is phosphorylated by CK2. Phosphorylation of The ability of TBB to prevent the PMA-induced phos-
HO2 Activation by CK2 during Neurotransmission
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odorants in cultured olfactory receptor neurons (ORNs)
(Ingi and Ronnett, 1995). These neurons are useful for
selectively assessing CO-dependent neurotransmis-
sion, because they lack postnatal expression of nNOS
(Ingi and Ronnett, 1995). Mixed odorant stimulation of
ORN cultures increases HO2 activity 60%, an effect
blocked by CK2 inhibition (Figures 4A and 4B). Odorant
stimulation of HO2 activity is accompanied by a signifi-
cant increase in HO2 phosphorylation, which is blocked
by TBB (Figure 4C). Phosphorylation of the CK2  sub-
unit is also increased in response to odorants (Figure
4D). In contrast to phorbol ester-stimulated hippocam-
pal cultures, GFX has no effect on HO2 activation or
phosphorylation in ORN cultures (Figures 4A–4D).
We next examined HO2-dependent modulation of
cGMP levels. TBB causes a small but statistically signifi-
cant reduction in basal cGMP levels in these cultures
(Figure 4E). Odorant stimulation of ORN cultures in-
creases cGMP levels 80%, an effect that is blocked by
CK2 inhibition (Figure 4F). The Ki for TBB blockade of
odorant effects on cGMP is 6.2 M, resembling the in
vitro potency of TBB against CK2 (Figure 4G; Szyszka
et al., 1995). As in hippocampal cultures, the TBB analog
DRB fails to influence cGMP levels (Figure 4G). PKC
inhibition by GFX does not affect odorant-dependent
increases in cGMP levels (Figures 4E and 4F). Thus, in
contrast to hippocampal cultures, in olfactory neurons
PKC-independent signaling mechanisms result in CK2
phosphorylation and activation of HO2.
Figure 2. Phosphopeptide Maps of In Vitro and In Vivo Phosphory-
lated HO2 NANC Relaxation of the Internal Anal Sphincter
HO2 expressed in COS-7 cells was phosphorylated by CK2 as in Is Modulated by CO and Requires CK2 Activity
Figure 1. Two-dimensional phosphopeptide mapping was per- To assess whether CK2 phosphorylation and activation
formed exactly as described (Ferris et al., 1991). of HO2 regulates CO-mediated neurotransmission in
(A) One major phosphopeptide spot appears when wt HO2 is phos- whole tissues, we monitored NANC neurotransmission
phorylated in vitro by CK2 (highlighted with a solid circle).
in the internal anal sphincter (IAS) of mice (Figure 5).(B) Phosphopeptide map produced from CK2 phosphorylation of
These preparations display NANC relaxation followingS79A in vitro. Expression levels of S79A were similar to wt (data not
shown). (A) and (B) are from the same experiment with identical electrical field stimulation (Figure 5A). No reduction in
exposures, and the kinase reactions were assembled using a master NANC transmission occurs in mice with targeted dele-
mix to ensure equal amounts of CK2 and substrates in all reactions. tion of nNOS (nNOS/). By contrast, in HO2/ mice
(C) Phosphopeptide map produced from HO2 immunoprecipitated and in HO2//nNOS/ double knockouts, we observe
from PMA-stimulated hippocampal cultures (500 nM). The origin is
about a 50% reduction in NANC transmission, establish-indicated by a black circle. These experiments were replicated three
ing that CO is a mediator of NANC transmission in thetimes with similar results. Unstimulated hippocampal cultures re-
sulted in blank phosphopeptide maps (data not shown). mouse IAS. The HO2 inhibitor tin protoporphyrin IX
blocks NANC transmission in the mouse IAS of wt mice
to a similar extent as genomic deletion of HO2, sug-
phorylation and activation of HO2 suggests that PKC gesting that compensatory changes due to HO2 deletion
activation stimulates CK2 activity. In hippocampal cul- are not responsible for reduced relaxation in the HO2
tures, a 3-fold increase in CK2 activity is observed fol- knockout animals (data not shown). As we have shown
lowing treatment with 500 nM PMA (Figure 3D). Inhibition previously in the small intestine (Zakhary et al., 1997),
of PKC and CK2 with GFX and TBB, respectively, blocks tin protoporphyrin IX has no effect on NANC relaxation
this stimulation. PMA treatment leads to increased of the IAS in HO2/ animals (data not shown). The simi-
phosphorylation of the  subunit of CK2 (Figure 3E), larity in response in NANC transmission to genetic dele-
implying that PKC directly phosphorylates and activates tion of HO2 and to tin protoporphyrin IX supports the
CK2. In support of this hypothesis, purified PKC robustly specificity of this substance as an HO inhibitor, confirm-
phosphorylates purified CK2 in vitro (Figure 3F), as pre- ing other reports (Meffert et al., 1994; Zakhary et al.,
viously reported by others (Sanghera et al., 1992). 1996).
To determine whether CK2 phosphorylation and acti-
vation of HO2 mediates NANC transmission, we treatedHO2/CO-Dependent Neurotransmission
in Olfactory Receptor Neurons Requires IAS preparations with TBB (Figure 5B). TBB reduces
NANC transmission in wild-type preparations by 80%,CK2 Activity
To investigate the regulation of HO2 by CK2 in a physio- with a similar reduction in preparations from nNOS/
mice. By contrast, we observe no significant reductionlogically relevant paradigm, we assayed the HO2/CO-
dependent stimulation of cGMP levels in response to in relaxation in HO2/ mice exposed to TBB. The failure
Neuron
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Figure 3. PMA Treatment of Hippocampal Neurons Causes Phosphorylation and Activation of HO2 by CK2
(A) HO2 activity in hippocampal cultures treated with 500 nM PMA for 5 min in the presence or absence of the PKC inhibitor GFX (5 M), the
CK2 inhibitor TBB (10 M), or DRB (10M). DRB is a related TBB analog, which is 40-fold less potent at inhibiting CK2 in vitro (Szyszka et
al., 1995). Activity was measured as in Figure 1 and is a representative experiment from five separate determinations.
(B) HO2 activity as percent of control pooled from five separate determinations. Data are presented as means  SEM. p values versus vehicle
are indicated.
(C) Metabolically labeled hippocampal cultures were treated with DMSO (vehicle), 100 nM or 500 nM PMA for 5 min in the presence or
absence of kinase inhibitors. HO2 was immunoprecipitated, run on an SDS-PAGE gel, and silver stained prior to autoradiography. Phosphate
incorporation was quantified by band excision and Cherenkov scintillation counting. Data are expressed as mean percent increase  SEM
relative to basal values from four experiments and were corrected for total protein levels as determined by silver stained band intensity. p
values for TBB and GFX pretreatment are versus DMSO pretreatment at the same concentration of PMA. The dashed line indicates no change
from basal.
(D) CK2 activity in hippocampal cultures treated with indicated concentrations of PMA. Reactions were performed as described elsewhere
(Song et al., 2000). Data are presented as means  SEM of five determinations performed in triplicate.
(E) Metabolically labeled hippocampal cultures were treated with 500 nM PMA for 5 min. CK2 was immunoprecipitated for quantification of
phosphate incorporation as in (C). Data are expressed as mean percent increase  SEM relative to basal from three experiments and were
corrected for total protein levels as determined by silver stained band intensity. The dashed line indicates no change from basal. p value
versus control (DMSO treatment) is indicated.
(F) Kinase reactions containing purified CK2, PKC, or both were performed for 10 min at 30C. Lanes 1 and 2 are autophosphorylation products.
PKC cannot autophosphorylate using [32P]GTP as a phosphate donor and including 5 M GFX in the incubation (lane 3). CK2 cannot
autophosphorylate in the presence of 10 M TBB and 100 g/ml heparin (lane 5). Lane 4 demonstrates CK2 phosphorylation of PKC. Lane
6 indicates PKC phosphorylation of CK2. PKC purified from rat brain was obtained from Promega Corporation (Madison, WI).
of TBB to influence the residual relaxation in HO2/ transmission in the IAS (data not shown). Therefore,
in both the IAS and ORN cultures, PKC-independentanimals supports its selectivity as a CK2 inhibitor, con-
sistent with other studies (Sarno et al., 2001). As in olfac- pathways can lead to CK2 activation and subsequent
HO2 activation.tory cultures, GFX and the pharmacologically distinct
PKC inhibitor calphostin C do not affect NANC neuro- To test the specificity of TBB in inhibiting IAS relax-
HO2 Activation by CK2 during Neurotransmission
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ation, we utilized a series of TBB derivatives that vary ish relaxation (O’Kelly et al., 1993; Tomita et al., 1999).
By contrast, other studies have demonstrated HO2 im-in their potencies as kinase inhibitors (Figure 5C). Since
the bioavailability of compounds in intact tissues may munoreactivity in neurons of the myenteric plexus in-
nervating the IAS (Battish et al., 2000; Ny et al., 1997)vary, drug potencies may differ between purified en-
zymes and intact tissues. Nonetheless, we observe an and inhibition of NANC relaxation by HO inhibitors (Rat-
tan and Chakder, 1993, 2000), supporting our conclusionassociation between CK2 inhibitory potency and inhibi-
tion of NANC transmission. TCB (4,5,6,7-tetrachloro- that CO participates in NANC relaxation of the IAS. TBB
blocked CO-dependent IAS relaxation, demonstratingbenzotriazole), whose CK2 inhibitory potency is about
6-fold lower than that of TBB (Szyszka et al., 1995), that CK2 is critical for HO2-mediated NANC neurotrans-
mission. Utilizing a series of TBB derivatives, we foundreduces NANC transmission to a similar extent as TBB.
By contrast, DRB and 4,5,6-trichloro-1-(-D-ribofurano- a correlation between potency in inhibiting CK2 and
ability to block IAS relaxation, establishing TBB’s speci-syl) benzimidazole (4Cl-DRB), which are substantially
less potent than TBB and TCB as CK2 inhibitors, have ficity. Specificity was further supported by the failure
of TBB to influence the residual relaxation in HO2/negligible effects on NANC relaxation. DiBr-DRB (5,6-
dibromo-1-(-D-ribofuranosyl) benzimidazole), interme- animals.
The activation of CK2 and its role in neuronal signalingdiate in potency between TBB and DRB, inhibits NANC
transmission but to a lesser extent than TBB and TCB. have remained somewhat enigmatic (for review, see
Blanquet, 2000a). Our results indicate that PKC can sig-Thus, the potencies of the TBB derivatives in inhibiting
NANC relaxation fit with their relative potencies as nificantly increase CK2 activity in hippocampal cultures,
possibly by direct phosphorylation of the  subunit. InCK2 inhibitors.
addition to activation by PKC, increased CK2 activity
following neuronal activity depends upon elevation ofDiscussion
cytosolic calcium (Blanquet, 1998, 2000b; Charriaut-
Marlangue et al., 1991). We found that HO2 activationA major finding of this study is that phosphorylation of
during odorant stimulation of olfactory neurons or NANCHO2 at serine 79 by CK2 is associated with a significant
relaxation of IAS did not require PKC activity. Since bothstimulation of enzymatic activity both in vitro and in
of these stimuli increase the cytosolic Ca2 concentra-intact cells and tissues. We also investigated whether
tion, it is possible that calcium-sensitive but PKC-inde-PKA, PKG, or PKC could phosphorylate CK2 in vitro.
pendent stimulation of CK2 leads to activation of HO2We found that HO2 is a poor substrate for these kinases
in these systems. TBB inhibited odorant-dependentrelative to CK2. We previously reported that activating
phosphorylation of the CK2  subunit (Figure 4D), sug-PKC via phorbol ester treatment results in the phosphor-
gesting that autophosphorylation of the  subunit oc-ylation and activation of HO2 in hippocampal and corti-
curs following odorant stimulation. This may be indica-cal cultures (Dore et al., 1999). We now show that PKC
tive of a mechanism for CK2 activation in ORN culturesdirectly phosphorylates and activates CK2, which in turn
in response to odorants. However, autophosphorylationphosphorylates and activates HO2. This is consistent
of the  subunit of CK2 is poorly understood, and thewith previous results demonstrating that PKC stimula-
functional consequences of this modification are nottion increases CK2 activity (Sanghera et al., 1992; Silva-
known. Finally, GFX is ineffective against the “atypical”Neto et al., 2002) and provides a molecular pathway
PKC isoforms  and 	 (Martiny-Baron et al., 1993; Uberallleading to HO2 activation during neuronal depolarization
et al., 1997), which could phosphorylate and activateinvolving calcium entry and PKC activation, subsequent
CK2 in ORN cultures and IAS preparations. In supportCK2 activation, and the phosphorylation of HO2 leading
of this hypothesis, PKC- binds CK2 in vivo to regulateto increased CO synthesis.
I
B turnover and phosphorylates the  and  subunitsTo establish the physiologic relevance of CK2 activa-
of CK2 in vitro (Bren et al., 2000). Current experimentstion of HO2, we demonstrated that odorant stimulation
are directed at testing these hypotheses to determineof HO2 activity and cGMP levels in ORNs is abolished
the mechanism(s) of CK2 activation in ORN cultures andby CK2 inhibitors (Figure 4). The role of HO2/CO in stimu-
IAS preparations.lating sGC in ORN preparations is well characterized,
Our results provide a mechanism by which CO can beand ORNs are an ideal system for these studies because
rapidly synthesized following neuronal depolarization.they lack endogenous nNOS activity (Ingi et al., 1996a,
CK2-dependent activation of HO2 was identified in mul-1996b; Ingi and Ronnett, 1995; Verma et al., 1993). Fur-
tiple experimental paradigms, including odorant signal-thermore, the experiments were performed in the pres-
ing in ORNs and NANC relaxation of ex vivo intestinalence of IBMX, eliminating possible artifacts resulting
preparations, suggesting that CK2 activation of HO2 isfrom effects of TBB on phosphodiesterase activity. DRB,
a generalized mechanism for stimulating CO synthesis.a structurally related but much less potent analog of
These results strongly support the already extensiveTBB, had no effect on odorant-stimulated HO2 activity
evidence that CO functions as a neuromodulator andor cGMP production. TBB partially reduced basal cGMP
provides a molecular mechanism linking depolarizationlevels in ORNs, indicating that CK2 regulates both basal
to CO synthesis.and stimulated HO2 activity.
Electric field stimulation of IAS segments from wt,
Experimental ProceduresnNOS, and HO2 knockout mice revealed a critical role
for HO2 in IAS relaxation, a conclusion supported by a
Molecular Biology
similar reduction in IAS NANC transmission elicited by Human HO2 was N-terminally myc-tagged by PCR and subcloned
the HO inhibitor tin protoporphyrin IX (data not shown). into EcoR1/NotI sites of pcDNA3.1 (Invitrogen, Carlsbad, CA). Site-
directed mutations were introduced using the QuickChange Site-In human IAS, NOS inhibitors have been shown to dimin-
Neuron
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Figure 4. Odorant-Dependent Increases in HO2 Phosphorylation, Catalytic Activity, and cGMP Levels in Olfactory Receptor Neurons Require
CK2 Activity
(A) Effect of kinase inhibitors on odorant-stimulated HO2 activity. HO2 activity in ORN cultures treated with 100 nM each of mixed odorants
(isobutylmethoxypyrazine, citralva, and iso-valeric acid) for 5 min in the presence or absence of GFX (5 M), TBB (10 M), or both. Activity
was measured as in Figure 1 and is a representative experiment from four separate determinations.
(B) HO2 activity as percent of control pooled from four separate determinations. Data are presented as means  SEM. p values versus vehicle
are indicated.
(C) Effect of kinase inhibitors on odorant-stimulated HO2 phosphorylation. ORN cultures labeled with [32P]orthophosphate were treated with
DMSO (vehicle) or mixed odorants for 5 min in the presence or absence of kinase inhibitors. HO2 phosphorylation was quantified as in Figure
3. Data are expressed as mean percent increase  SEM relative to basal values from four experiments and were corrected for total protein
levels as determined by silver stained band intensity. p values versus no odorant are indicated. The dashed line indicates no change from
basal. A representative autoradiogram is shown.
(D) Effect of kinase inhibitors on odorant-stimulated CK2 phosphorylation. CK2 phosphorylation in ORN cultures determined exactly as in (C)
by immunoprecipitating CK2. A representative autoradiogram is shown.
(E) Effect of kinase inhibitors on basal cGMP levels. Basal cGMP levels in ORN cultures were measured in the presence or absence of GFX
or TBB. Bars represent the mean  SEM of six separate determinations performed in triplicate. Results are expressed as a percentage of
control (DMSO treatment) due to variability in basal cGMP levels between individual ORN preparations. p values versus control DMSO treatment
are indicated.
(F) Effect of kinase inhibitors on odorant-stimulated cGMP levels. Mixed odorant stimulation of cGMP levels in ORN cultures in the presence
HO2 Activation by CK2 during Neurotransmission
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directed Mutagenesis Kit (Stratagene, La Jolla, CA). Forward primers
(5-3) were as follows: S79A, TACTTCACATACGCAGCCCTCGAG
GAG; S179A, CTGAAACTCCCCGCCACAGGGGAAGGG; T248A, CTG
GCCAGAGAGGCCTTGGAGGATGGG. Reverse primers were the ex-
act complement of forward primers. All mutations were confirmed
by automated sequencing.
In Vitro Kinase Reactions
HO2 was transiently overexpressed in COS-7 cells, and 200 g of
lysate was immunoprecipitated in buffer A (150 mM NaCl, 50 mM Tris
7.8, 1 mM EDTA, 1% Triton, protease inhibitors) with myc antibody
(Roche Applied Science, Indianapolis, IN) for 2 hr at room tempera-
ture. The immunoprecipitates were washed three times with buffer
A and kinase reactions were performed directly on the beads at
30C with purified recombinant CK2 (New England Biolabs, Beverly,
MA) as per manufacturer’s protocol. Reactions were supplemented
with 10 Ci/ml [-32P]ATP (PerkinElmer Life Sciences, Boston, MA),
100 M MgATP, and 5 mM spermine. Since CK2 runs at a similar
mobility on SDS-PAGE as HO2, it was necessary to wash the beads
three times with buffer A after the kinase reaction to remove the
autophosphorylated kinase, and washed beads were quenched with
SDS-PAGE sample buffer. Samples were run on SDS-PAGE with
bovine serum albumin (BSA) standards of 1, 5, 10, and 100 ng.
Gels were subsequently silver stained, dried, and autoradiographed.
Total HO2 protein immunoprecipitated was quantified by densitom-
etry of the BSA standards and HO2 bands using a Stratagene Eagle
Eye II system (Stratagene, La Jolla, CA) and extrapolating total nano-
grams of HO2 based on the BSA curve. Radioactivity associated with
each band was quantified by band excision and counting Cherenkov
radiation in a scintillation counter.
HO2 Assays
HO2 assays were performed as described previously with modifica-
tions (Ferris et al., 1999). Briefly, HO2 activity was measured by
incubating microsomal vesicles with 15M [55Fe]hemin (PerkinElmer
Life Sciences) and 1 mM NADPH at 30C for 6 min. Reactions were
terminated, and uncleaved heme and biliverdin were removed from
liberated 55Fe in one step by vortexing the reactions in an equal
volume phenol:chloroform:isoamyl alcohol (25:24:1) for 5 min at
room temperature. Samples were centrifuged for 5 min at 16,000 g
at room temperature and 55Fe in the aqueous phase was quantified
by liquid scintillation counting. Data are expressed either as nmoleFigure 5. CK2 Activity Is Required for HO2-Mediated NANC Neuro-
or pmole/mg/min from a single experiment performed in duplicatetransmission in the Internal Anal Sphincter
or as % activity relative to control pooled from 3–5 separate experi-(A) Internal anal sphincter (IAS) from wt, HO2/, nNOS/, or
ments.HO2//nNOS/ (DKO) mice was dissected and placed in an organ
bath, and NANC transmission was initiated by electric field stimula-
tion (EFS) administered sequentially at the frequencies listed. Re- Antibodies
sults are represented as mean percent  SEM of sodium nitroprus- Anti-GST-HO2 antibody has been described previously (Baranano
side-induced relaxation and are pooled from 3–5 experiments. The et al., 2000). CK2 antibody was purchased from Upstate Biotech-
frequency responses were fit to a nonlinear hyperbolic equation nology (Lake Placid, NY).
(solid lines) for statistical comparison. p  0.01 for HO2, DKO, and
wt IAS treated with tetrodotoxin (TTX) compared to wt. Metabolic Labeling
(B) Effects of 15 M TBB on relaxation in wt, nNOS/, and HO2/ Primary hippocampal and ORN cultures were metabolically labeled
mice. Stimulation frequency was 5 Hz. Tissue segments were first for 4 hr with 0.5 mCi/ml [32P]orthophosphate (PerkinElmer Life Sci-
stimulated in the absence of drug to obtain a control response ences) in phosphate and serum-free media before PMA or mixed
before testing the effect of TBB. Results are expressed as the per- odorant treatment. In some samples the neurons were pre-incu-
cent relaxation  SEM relative to the control relaxation in the ab- bated for 30 min with the PKC and CK2 inhibitors GFX (5 M) and
sence of TBB. DMSO (vehicle) had no effect (data not shown). TBB (10 M), respectively, before stimulation. Endogenous HO2 or
(C) Effects of various TBB analogs on relaxation. All drugs were CK2 from treated neurons were immunoprecipitated with HO2- or
added at a concentration of 15 M and analyzed as in Figure 4B. CK2-specific antibodies, run on SDS-PAGE, silver stained, and
Previously determined Ki values of each drug at inhibiting purified autoradiographed. Quantification of phosphate incorporation was
CK2 in vitro are listed (Dobrowolska et al., 1991; Meggio et al., 1990; done as described above for the in vitro kinase reactions, with total
Sarno et al., 2001; Szyszka et al., 1995). p values versus control counts of radioactivity associated with each band being normalized
(DMSO treatment) are indicated. to total protein immunoprecipitated. Background was subtracted
by excising a nonrelevant portion of each lane.
or absence of GFX and TBB. Results, expressed as a percentage of basal cGMP levels, are pooled from three separate experiments performed
in triplicate. Dashed line indicates no change in cGMP levels relative to basal. p values versus DMSO treatment are indicated.
(G) Dose dependence of TBB inhibition of mixed odorant stimulation of cGMP ORN cultures. The effect of DRB at 10 M is also plotted (open
circle). The data were fit to a four parameter nonlinear Hill equation to determine Ki values. All experiments were performed in the presence
of the cGMP phosphodiesterase inhibitor IBMX (0.5 mM).
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Primary Culture of Hippocampal Neurons lated in the absence of drug to obtain a control relaxation, then the
medium was replaced with fresh NANC drugs and the inhibitor forPrimary culture of hippocampal neurons was exactly as described
previously (Brewer et al., 1993; Dore et al., 1997). 15 min before EFS was administered in the presence of drug. Mock-
treated (DMSO) tissues produced relaxations not significantly differ-
ent from control (data not shown).Primary Culture of Olfactory Receptor Neurons
Cultures were prepared as described previously (Ronnett et al.,
1991) with modification. 1- to 2-day-old rat pups (100 per prepara- Ki Determination
tion) were killed by decapitation, and olfactory tissue was dissected Ki value in Figure 4C was determined by fitting the data to the
and immediately placed in modified Eagle’s medium (MEM) con- four parameter logistic equation y  min  (max  min)/(1 
taining 4.8 gm/l of HEPES buffer (pH 7.4) designated MEM-AIR. (x-EC50)^Hillslope) using SigmaPlot software (SPSS Science, Chi-
The suspension was transferred twice through fresh MEM-AIR to cago, IL).
minimize contamination and centrifuged at 700  g for 7 min. After
the supernatant was decanted, the tissue was minced to achieve Statistical Analysis
fragments of about 1 mm in size, resuspended in MEM-AIR, and In all experiments except Figure 4A, statistical significance was
centrifuged at 700  g for 7 min. Tissue was placed in 30 ml of determined using unpaired two-tailed t tests. To statistically com-
MEM-AIR containing 1% (w/v) BSA, RIA grade (Sigma, St. Louis, pare the EFS frequency response between genotypes in Figure 4A,
MO), 1 mg/ml hyaluronidase (Sigma), and 50 g/ml dispase (Boeh- the data were fit to a hyperbolic curve. The data could be described
ringer Mannheim, Indianapolis, IN) and incubated with agitation for by the equation y A(x)/(B x), where Amaximum relaxation and
1 hr at 37C. At the end of incubation, the cell suspension was B  the frequency that elicits a 1/2 maximal relaxation. Statistical
centrifuged at 500  g for 5 min. The supernatant was aspirated, significance was determined by comparing the mean  SEM of
and the cell pellet was resuspended in plating medium composed variable “A” pooled from all experiments. Curve fitting was per-
of MEM containing D-valine (MDV; Life Technologies, Gaithersburg, formed using Prism software (Graphpad Software, Inc., San
MD) containing 15% (v/v) dialyzed fetal calf serum (dFCS; Life Tech- Diego, CA).
nologies), 5% (v/v) NU serum (Collaborative Research, Bedford, MA).
After resuspension, cells were successively filtered through 50 and
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